Scarica l'app Stockscreener
99.78
3.28%
-3.38
Dopo l'orario di chiusura:
99.78
Rhythm Pharmaceuticals Inc Borsa (RYTM) Ultime notizie
Is Rhythm Pharmaceuticals Inc vulnerable to short sellersWeekly Trade Summary & Weekly High Return Opportunities - baoquankhu1.vn
Royal Bank Of Canada Upgrades Rhythm Pharmaceuticals (NASDAQ:RYTM) to Moderate Buy - MarketBeat
Rhythm Pharmaceuticals (NASDAQ:RYTM) CFO Hunter Smith Sells 3,569 Shares - MarketBeat
Insider Sell: Hunter Smith Sells Shares of Rhythm Pharmaceuticals Inc (RYTM) - GuruFocus
Rhythm pharmaceuticals CFO Smith sells $805k in shares By Investing.com - Investing.com UK
Rhythm pharmaceuticals CFO Smith sells $805k in shares - Investing.com
Expert Outlook: Rhythm Pharmaceuticals Through The Eyes Of 11 Analysts - Benzinga
Rhythm Pharmaceuticals Is Well-Positioned, Analyst Says Could Capture Big Share Of Rare Obesity Market - Benzinga
Rhythm Pharmaceuticals Seen Poised for Growth in Rare Genetic Obesity, RBC Says - marketscreener.com
RBC Capital Initiates Coverage on Rhythm Pharmaceuticals With OutperformSpeculative Risk Rating, $145 Price Target - marketscreener.com
Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: Should You Buy? - Finviz
RBC Capital Initiates Coverage on RYTM with 'Outperform' Rating - GuruFocus
RBC Capital Initiates Coverage of Rhythm Pharmaceuticals (RYTM) with Outperform Recommendation - Nasdaq
Rhythm Pharmaceuticals (NASDAQ:RYTM) Upgraded by Zacks Research to Hold Rating - MarketBeat
Readystate Asset Management LP Sells 16,301 Shares of Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
RBC Capital initiates Rhythm Pharmaceuticals stock with outperform rating - Investing.com
How The Rhythm Pharmaceuticals RYTM Story Is Shifting With Imcivree Revenue And New Targets - Yahoo Finance
Rhythm Pharmaceuticals (RYTM) to Release Quarterly Earnings on Wednesday - MarketBeat
IPO Launch: Can Rhythm Pharmaceuticals Inc expand into new marketsJuly 2025 Momentum & Technical Confirmation Alerts - baoquankhu1.vn
Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026 - The Manila Times
Rhythm Pharmaceuticals to Report Fourth Quarter and Full - GlobeNewswire
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Rhythm Pharma label expansion requests for obesity drug undergo U.S. EU reviews - MSN
Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A 44% Upside Potential in the Biotech Space - DirectorsTalk Interviews
Trading Systems Reacting to (RYTM) Volatility - Stock Traders Daily
Rhythm Pharmaceuticals Eyes March 20 HO PDUFA, Highlights IMCIVREE Growth at Guggenheim Conf. - MarketBeat
Will Rhythm Pharmaceuticals Inc. stock remain a Wall Street favoriteJuly 2025 Big Picture & Daily Technical Stock Forecast Reports - mfd.ru
Assessing Rhythm Pharmaceuticals (RYTM) Valuation After Recent Share Price Weakness - Sahm
Rhythm Pharmaceuticals (NASDAQ:RYTM) CFO Sells $272,755.26 in Stock - MarketBeat
Rhythm Pharmaceuticals (NASDAQ:RYTM) CFO Hunter Smith Sells 1,592 Shares - MarketBeat
Rhythm’s LB54640 Trial Completion Sets Up Key Catalyst in Hypothalamic Obesity - TipRanks
Jobs Data: Is Atossa Therapeutics Incs growth already priced inJuly 2025 Price Swings & Stepwise Swing Trade Plans - baoquankhu1.vn
Hunter Smith Sells 2,713 Shares of Rhythm Pharmaceuticals (NASDAQ:RYTM) Stock - MarketBeat
Rhythm Pharmaceuticals at Guggenheim Summit: Expanding Horizons in Biotech By Investing.com - Investing.com Canada
Is Rhythm Pharmaceuticals Inc. stock risky to hold now2025 Price Targets & Long-Term Growth Stock Strategies - mfd.ru
Earnings Risk: Is Rhythm Pharmaceuticals Inc currently under institutional pressure2025 Volume Leaders & Low Volatility Stock Suggestions - baoquankhu1.vn
Candriam S.C.A. Lowers Position in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
What are Rhythm Pharmaceuticals Inc.’s recent SEC filings showingChart Signals & Community Consensus Trade Alerts - mfd.ru
Rhythm Pharmaceuticals prices $175M stock offering - MSN
Bond Watch: Will Rhythm Pharmaceuticals Inc benefit from green energy policies2025 Growth vs Value & Short-Term Trading Alerts - baoquankhu1.vn
Smith, Rhythm Pharmaceuticals CFO, sells $702k in RYTM stock - Investing.com Australia
Smith, Rhythm Pharmaceuticals CFO, sells $702k in RYTM stock By Investing.com - Investing.com Canada
Rhythm Pharmaceuticals (NASDAQ:RYTM) CFO Sells $358,588.86 in Stock - MarketBeat
Penserra Capital Management LLC Acquires Shares of 30,436 Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
Rhythm Pharmaceuticals' CFO Hunter C. Smith to Speak at Guggenheim Emerging Outlook: Biotech Summit 2026 - Quiver Quantitative
Rhythm Pharmaceuticals Announces Participation in Upcoming Guggenheim Biotech Summit - GlobeNewswire
Rhythm Pharmaceuticals, Inc. $RYTM Shares Acquired by New York State Common Retirement Fund - MarketBeat
How Rhythm Pharmaceuticals Inc. (RYTM) Affects Rotational Strategy Timing - Stock Traders Daily
WCM Investment Management LLC Makes New Investment in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
This High-Flying Growth Stock Is Hiding in Plain Sight - Finviz
Federated Hermes Inc. Has $174.50 Million Position in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
EFG Asset Management North America Corp. Invests $2.05 Million in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat
Bank Watch: Will Rhythm Pharmaceuticals Inc stock go up in YEARMarket Weekly Review & Daily Price Action Insights - baoquankhu1.vn
Aug Breakouts: What hedge funds are buying Rhythm Pharmaceuticals IncWall Street Watch & AI Powered Market Entry Ideas - baoquankhu1.vn
Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Exploring a 37.5% Potential Upside in Biotech - DirectorsTalk Interviews
Aug Technicals: Is INVO Fertility Inc stock heavily shortedJuly 2025 Earnings & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
(RYTM) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
0.34%
0.89%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):